Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV004584488 | SCV002577764 | pathogenic | See cases | 2021-12-04 | criteria provided, single submitter | clinical testing | ACMG categories: PVS1,PM2,PP4 |
Labcorp Genetics |
RCV003097723 | SCV003275649 | pathogenic | not provided | 2022-01-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1244*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003454076 | SCV004182308 | pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing |